Respiratory Syncytial Virus Infections - 27 Studies Found

Completed : Safety Study of Oral BTA9881 to Treat RSV Infection
: Respiratory Syncytial Virus Infections
: 2007-07-18
:
  • Drug: BTA9881 Single oral esca
Terminated : Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
: Respiratory Syncytial Virus Infections
: 2002-03-06
: Drug: Virazole (Ribavirin) Inhalation Solution
Completed : Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children
: Respiratory Syncytial Virus Infection
: 2008-01-03
Completed : A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT
: Respiratory Syncytial Virus Infections
: 2005-10-04
: Drug: A-60444
Active, not recruiting : Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
: Respiratory Syncytial Virus Infections
: 2014-12-21
:
  • Drug: REGN2222
  • Drug: Placebo
Completed : Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)
:
  • Respiratory Syncytial Virus Infections
  • Infections, Epidemics : 2013-07-26
Completed : Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions
: Respiratory Syncytial Virus Infection
: 2011-09-12
: Drug: Palivizumab Other Names:
  • ABT-315
  • Synagis
Completed : ALX-0171 Safety Study in Adults With Hyperresponsive Airways
: Respiratory Syncytial Virus Infection
: 2013-07-24
: Biological: ALX-0171 Escalating dose of ALX-0171 during maximum 3 consecutive days: from 2.1 mg to maxim
Completed : Surveillance of Synagis in Korean Pediatric Patients
: Respiratory Syncytial Virus Infection
: 2011-12-15